Zusammenfassung
Von der Elektrophysiologie, der Rezeptorausstattung und der Wirkung von Pharmaka her lassen sich 2 Gruppen der glatten Muskulatur differenzieren: intestinaler und vaskulärer Typ, Die glatte Muskulatur des Bronchialsystems nimmt eine Mittelstellung ein.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Ahlner J, Andersson RGG, Torfgard K, Axelsson KL (1991) Organic nitrate esters: Clinical use and mechanisms of actions. Pharmacol Rev 43:351–423
Anggard E (1994) Nitric oxide: Mediator, murderer, and medicine. Lancet 343:1199–1206
Atwal KS (1992) Modulation of potassium channels by organic molecules. Med Res Rev 12:569–591
Beavo JA (1995) Cyclic nucleotide phosphodiesterases: Functional implications of multiple isoforms. Physiol Rev 75:725–748
Berridge MJ (1993) Inositol trisphosphate and calcium signalling. Nature 361:315–325
Bootman MD, Berridge MJ (1995) The elemental principles of calcium signaling. Cell 83:675–678
Callewaert G (1992) Excitation-contraction coupling in mammalian cardiac cells. Cardiovasc Res 26:923–932
Cantin M, Genest J (1985) The heart and the atrial natriuretic factor. Endocr Rev 6:107–127
Catterall WA (1995) Structure and function of voltage-gated ion channels. Annu Rev Biochem 64:493–531
Catterall WA, Striessnig J (1992) Receptor sites for Ca2+ channel antagonists. Trends Pharmacol Sci 13:256–262
Conti M, Jin S-LC, Monaco L, Repaske DR, Swinnen JV (1991) Hormonal regulation of cyclic nucleotide phosphodiesterases. Endocr Rev 12:218–234
Davies NM, Standen NB, Stanfield PR (1991) ATP-dependent potassium channels of muscle cells: Their properties, regulation, and possible functions. J Bioenerg Biomembr 23:509–535
De Weille JR (1992) Modulation of ATP sensitive potassium channels. Cardiovasc Res 26:1017–1020
De Zeeuw D, Janssen WMT, De Jong PE (1992) Atrial natriuretic factor: Its (patho)physiological significance in humans. Kidney Int 41:1115–1133
Dolphin AC (1991) Regulation of calcium channel activity by GTP binding proteins and second messengers. Biochim Biophys Acta 1091:68–80
Elkayam U (1991) Tolerance to organic nitrates: Evidence, mechanisms, clinical relevance, and strategies for prevention. Ann Intern Med 114:667–677
Fasolato C, Innocenti B, Pozzan T (1994) Receptor-activated Ca2+ influx: How many mechanisms for how many channels. Trends Pharmacol Sci 15:77–83
Ferro CJ, Webb DJ (1996) The clinical potential of endothelin receptor antagonists in cardiovascular medicine. Drugs 51:12–27
Fleckenstein A (1983) History of calcium antagonists. Circ Res 52 [Suppl I]:3–16
Galen PJM van, Stiles GL, Michaels G, Jacobson KA (1992) Adenosin A1 and A2 receptors: Structure-function relationships. Med Res Rev 12:423–471
Garbers DL, Koesling D, Schultz G (1994) Guanylyl cyclase receptors. Mol Biol Cell 5:1–5
Gerzer R (1985) Das Herz, ein endokrines Organ: Die Entdeckung eines neuen Hormons. Klin Wochenschr 63:529–536
Glossmann H, Striessnig J (1990) Molecular properties of calcium channels. Rev Physiol Biochem Pharmacol 114:1–105
Goldmann B, Stoltefuss J (1991) 1,4-dihydropyridines: Effects of chirality and conformation on the calcium antagonist and calcium agonist activities. Angew Chem (Int Ed Engl) 30:1559–1578
Grobecker H (1994) Calciumantagonisten. Med Monatsschr Pharm 17:130–139
Hellwig B (1994) Kaliumagonisten. Med Monatsschr Pharm 17:164–167
Hess P (1990) Calcium channels in vertebrate cells. Annu Rev Neurosci 13:337–356.
Hofmann F, Biel M, Flockerzi V (1994) Molecular basis for Ca2+ channel diversity. Annu Rev Neurosci 17:399–418
Hollenberg MD (1994) Tyrosine kinase pathways and the regulation of smooth muscle contractility. Trends Pharmacol Sci 15:108–114
Kam PCA, Govendeer G (1994) Nitric oxide: Basic science and clinical applications. Anaesthesia 49:515–521
Kamm KE, Stull JT (1985) The function of myosin and myosin light chain kinase phosphorylation in smooth muscle. Annu Rev Pharmacol Toxicol 25:593–620
Levin ER (1995) Endothelins. N Engl J Med 333:356–363
Masaki T (1995) Possible role of endothelin in endothelial regulation of vascular tone. Annu Rev Pharmacol Toxicol 35:235–255
Masaki T, Yanagisawa M (1992) Physiology and pharmacology of endothelins. Med Res Rev 12:391–421
Mayer B, John M, Heinzel B, Werner ER, Wachter H, Schultz G, Böhme E (1991) Brain nitric oxide synthase is a biopterin- and flavin-containing multi-functional oxido-reductase. FEBS Lett 288:187–191
Means AR, Van Berkum MFA, Bagchi I, Lu KP, Rasmussen CD (1991) Regulatory functions of calmodulin. Pharmacol Ther 50:255–270
Moncada S (1992) The 1991 Ulf von Euler Lecture, The L-argi-nine:nitric oxide pathway. Acta Physiol Scand 145:201–227
Moneada S, Higgs A (1993) The L-arginine-nitric oxide pathway. N Engl J Med 329:2002–2012
Nathan C, Xie QW (1994) Regulation of biosynthesis of nitric oxide. J Biol Chem 269:13725–13728
Pelzer D, Pelzer S, McDonald TF (1990) Properties and regulation of calcium channels in muscle cells. Rev Physiol Biochem Pharmacol 114:107–207
Pfaffendorf M (1992) Atriales natriuretisches Peptid als Angiotensin-II-Antagonist: Eine neues therapeutisches Prinzip? Med Monatsschr Pharm 15:169–177
Pietrobon D, Di Virgilio F, Pozzan T (1990) Structural and functional aspects of calcium homeostasis in eukaryotic cells. Eur J Biochem 193:599–622
Pongs O (1992) Structural basis of voltage-gated K+-channel pharmacology. Trends Pharmacol Sci 13:359–365
Porzig H (1990) Pharmacological modulation of voltage-dependent calcium channels in intact cells. Rev Physiol Biochem Pharmacol 114:209–262
Quast U, Guillon JM, Cavero I (1994) Cellular pharmacology of potassium channel openers in vascular smooth muscle. Cardiovasc Res 28:805–810
Quayle JM, Standen NB (1994) K-ATP channels in vascular smooth muscle. Cardiovasc Res 28:797–804
Rembold CM (1992) Regulation of contraction and relaxation in arterial smooth muscle. Hypertension 20:129–137
Reynen K (1993) Nitrate. Dtsch Med Wochenschr 118:1532–1539
Ruskoaho H (1992) Atrial natriuretic peptide: Synthesis, release, and metabolism. Pharmacol Rev 44:480–602
Saccomano NA, Ganong AH (1991) Diversity of neuronal calcium channels. Annu Rev Med Chem 26:33–41
Sanguinetti MC (1992) Modulation of potassium channels by antiarrhythmic and antihypertensive drugs. Hypertension 19:228–236
Scherübl H, Hescheler J (1992) Patch-clamp-Technik und Ionenkanäle: Bedeutung in der Medizin. Dtsch Ärztebl 89:B-215–B-218
Schmidt HHHW (1994) NO, endogener Botenstoff und Zellgift. Med Monatsschr Pharm 17:168–185
Schröder H (1992) Organische Nitrate: Neue Erkenntnisse zum Wirkungsmechanismus einer alten Substanzklasse. Med Monatsschr Pharm 15:134–139
Smyth EM, Keenan AK (1994) The vascular ANF-C receptor: Role in atrial peptide signalling. Cell Signal 6:125–133
Tang W-J, Gilman AG (1992) Adenylyl cyclases. Cell 70:869–872
Thompson WJ (1991) Cyclic nucleotide phosphodiesterases: Pharmacology, biochemistry and function. Pharmacol Ther 51:13–33
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Oberdisse, E. (1999). Pharmaka mit Wirkung auf den glatten Muskel. In: Oberdisse, E., Hackenthal, E., Kuschinsky, K. (eds) Pharmakologie und Toxikologie. Springer-Lehrbuch. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-98030-5_17
Download citation
DOI: https://doi.org/10.1007/978-3-642-98030-5_17
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-98031-2
Online ISBN: 978-3-642-98030-5
eBook Packages: Springer Book Archive